Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVLT | Common Stock | Sale | -$37.6K | -573 | -0.59% | $65.59 | 95.7K | May 19, 2023 | Direct | F1 |
transaction | CVLT | Common Stock | Award | $0 | +582 | +0.61% | $0.00 | 96.3K | May 22, 2023 | Direct | F2 |
transaction | CVLT | Common Stock | Award | $0 | +2.11K | +2.19% | $0.00 | 98.4K | May 22, 2023 | Direct | F3 |
transaction | CVLT | Common Stock | Sale | -$22.8K | -341 | -0.35% | $66.83 | 98.1K | May 23, 2023 | Direct | F4 |
transaction | CVLT | Common Stock | Sale | -$150K | -2.23K | -2.27% | $67.22 | 95.9K | May 23, 2023 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | Represents shares automatically sold solely to satisfy tax withholding obligations of reporting person on vesting of restricted stock. Proceeds from the sale were submitted to the Internal Revenue Service. |
F2 | Represents additional shares issued in connection with the Company's total shareholder return for fiscal year 2023 satisfying specified benchmarks relative to the Russell 3000 index pursuant to the terms of an award granted on May 22, 2020. |
F3 | Represents additional shares issued in connection with the Company's achievement of certain financial performance metrics tied to annualized recurring revenue for fiscal year 2023 pursuant to the terms of an award granted on May 16, 2022. |
F4 | The sale reported in this Form 4 was effected pursuant to an existing Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2023. The price reported represents all shares sold at $66.83. |